Parameter | Details |
---|---|
Research Question | “How has the COVID-19 pandemic impacted the ability of adult individuals diagnosed with schizophrenia or bipolar I disorder to access appropriate treatment, including the use of a long-acting injectable antipsychotic?” |
Individual Population | Adults aged ≥18 years. Literature Database Categories: Adult (18+ years); Young Adult (19–24 years); Adult (19–44 years); Middle Aged (45–64 years); Aged (65+ years); 80 and over (80+ years) |
Therapeutic Indication | Schizophrenia; Bipolar I Disorder |
Journal Type | Peer-reviewed |
Language | English |
Types of Evidence | Case Report; Observation Study; Clinical Study; Clinical Trial; Randomized Controlled Trial; Multicenter Study; Observational Study; Meta-analysis; Systematic Review |
Literature Databases | PubMed; OVID Medline; CINAHL |
Literature Type | Full text; Free Full Text; Open Access |
Time Period | January 1, 2020 – March 10, 2021 |